Pablo A. Romagnoli, PhD, is a researcher (Investigador Adjunto) with the National Scientific and Technical Research Council (CONICET), based at Centro de Investigación en Medicina Traslacional "Severo R. Amuchástegui" (CIMETSA), a CONICET-associated unit of the Instituto Universitario de Ciencias Biomédicas de Córdoba (IUCBC), Córdoba, Argentina. He obtained his B.S. in Biochemistry (Bioquímico Clínico) from the Universidad Nacional de Córdoba and his PhD in Immunology and Molecular Pathogenesis from Emory University (Atlanta, GA, USA), followed by postdoctoral training in mucosal immunology at UConn Health (Farmington, CT, USA) under Dr. Leo Lefrançois and Dr. Kamal M. Khanna. His research focuses on T cell memory, gut microbiota, and dietary metabolites in inflammatory bowel disease, and he has authored more than 27 peer-reviewed publications in journals such as PNAS, Immunity, and Mucosal Immunology. He has served as principal investigator or collaborator on numerous national and international research grants, including funding from FONCYT/ANPCyT, the Chan Zuckerberg Initiative, and the European Commission's Horizon 2020 program. He is a member of the Sociedad Argentina de Inmunología, the Latin American Mucosal Immunology Group, and the Society for Mucosal Immunology, and has received several international travel and research awards throughout his career.